Showing results (91-100 of 139) with videos related to

Sort By:
Pageof 14
Plos Medicine|December 7, 2016
Clonal Evolutionary Analysis during HER2 Blockade in HER2-Positive Inflammatory Breast Cancer: A Phase II Open-Label Clinical Trial of Afatinib +/- VinorelbineGerald Goh, Ramona Schmid, Kelly Guiver, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 9, 2020
Serum Alpha-fetoprotein Levels and Clinical Outcomes in the Phase III CELESTIAL Study of Cabozantinib versus Placebo in Patients with Advanced Hepatocellular CarcinomaRobin Kate Kelley, Tim Meyer, Lorenza Rimassa, et al.
Annals of Hepatology|December 26, 2025
Effect of pembrolizumab on viral hepatitis load and transaminases in advanced hepatocellular carcinomaStephen Lam Chan, Richard S Finn, Julien Edeline, et al.
Cancers|April 30, 2021
The Use of Cabozantinib in Advanced Hepatocellular Carcinoma in Hong Kong-A Territory-Wide Cohort StudyJeffrey Sum-Lung Wong, Yawen Dong, Vikki Tang, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|February 13, 2021
Thyroid Immune-Related Adverse Events in Patients with Cancer Treated with anti-PD1/anti-CTLA4 Immune Checkpoint Inhibitor Combination: Clinical Course and OutcomesDavid Tak Wai Lui, Chi Ho Lee, Vikki Tang, et al.
Journal for Immunotherapy of Cancer|November 29, 2023
Phase I/Ib, open-label, multicenter, dose-escalation study of the anti-TGF-β monoclonal antibody, NIS793, in combination with spartalizumab in adult patients with advanced tumorsTodd M Bauer, Armando Santoro, Chia-Chi Lin, et al.
Oncoimmunology|June 7, 2023
Trial watch: immunotherapeutic strategies on the horizon for hepatocellular carcinomaBenjamin Koh, Darren Jun Hao Tan, Wen Hui Lim, et al.
Cancer Research Communications|February 27, 2026
Impact of Hepatitis B Virus Infection on the Efficacy and Safety of Pembrolizumab Plus Chemotherapy for Advanced Biliary Tract Cancer in the KEYNOTE-966 StudyStephen L Chan, Thomas Yau, Robin K Kelley, et al.
Annals of Surgical Oncology|June 4, 2014
Genomic profiling of intrahepatic cholangiocarcinoma: refining prognosis and identifying therapeutic targetsAndrew X Zhu, Darrell R Borger, Yuhree Kim, et al.
Therapeutic Advances in Medical Oncology|December 20, 2019
A phase II study of the efficacy and safety of the MET inhibitor capmatinib (INC280) in patients with advanced hepatocellular carcinomaShukui Qin, Stephen Lam Chan, Wattana Sukeepaisarnjaroen, et al.
Pageof 14